Zentalis Pharmaceuticals, Inc. 10-K Cybersecurity GRC - 2025-03-26

Page last updated on March 26, 2025

Zentalis Pharmaceuticals, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-26 16:11:19 EDT.

Filings

10-K filed on 2025-03-26

Zentalis Pharmaceuticals, Inc. filed a 10-K at 2025-03-26 16:11:19 EDT
Accession Number: 0001725160-25-000067

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity and availability of our critical systems and information. Our cybersecurity program is aligned with industry standards and reasonable security safeguards for comparable companies in our industry. We reference various security industry frameworks and other guidance to help us assess, identify and manage cybersecurity risks. We also actively engage with industry participants as part of our continuing efforts to evaluate and enhance the effectiveness of our information security policies and procedures. We may engage consultants or other third parties from time to time to assist us with assessing and improving our cybersecurity program. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations or financial condition. We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. There can be no assurance that our cybersecurity risk management program and processes, including our policies, controls or procedures, will be fully implemented, complied with or effective in protecting our systems and information. See “Risk Factors-Risks Related to Employee Matters, Managing Our Growth and Other Risks Related to Our Business-Our business and operations may suffer in the event of information technology system failures, cyberattacks or deficiencies in our cybersecurity.” The Board considers cybersecurity risk as part of its overall risk oversight function and has delegated to the Audit Committee oversight of cybersecurity and information security risks, including oversight of management’s implementation of our cybersecurity risk management program. The Audit Committee receives periodic reports from management regarding our cybersecurity program. These reports include updates on our cybersecurity program and the status of projects to strengthen our information security systems. The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. Our management team, including our Chief Executive Officer, our Chief Legal Officer and our Executive Director, IT Infrastructure & Information Security , is responsible for assessing and managing our risks from cybersecurity threats. Certain members of our management team are part of our Cyber Incident Response Team and are responsible for executing the processes set forth therein, including with respect to our key third party service providers. Cybersecurity events are escalated to the Audit Committee or to our Board as appropriate. Our Executive Director, IT Infrastructure & Information Security, has close to thirty years of experience in information security, including twenty years of experience building and leading information security teams, and has held Certified Information Systems Security Professional certification from the 66 International Information System Security Certification Consortium since 2002, as well as Qualified Technical Expert certification from the Digital Directors Network. Our Chief Executive Officer has thirty years of experience overseeing information technology, or IT, functions and has eight years of experience serving on the audit committees of companies that had oversight responsibility of the company’s cybersecurity risk management program. Our Chief Legal Officer has overseen our IT team since 2023. Our management team takes steps to stay informed about and monitor efforts to prevent, detect, mitigate and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in our IT environment.


Company Information

NameZentalis Pharmaceuticals, Inc.
CIK0001725160
SIC DescriptionPharmaceutical Preparations
TickerZNTL - Nasdaq
Website
CategoryLarge accelerated filer
Fiscal Year EndDecember 30